Life-threatening hemorrhage from acquired factor V deficiency with non-inhibitory, hyperclearance-type antibodies successfully treated with rituximab then belimumab. - Tanaka-Mabuchi N; Hanai S; Ito R; Kubota S; Ikeda K; Yazaki M; Kobayashi Y; Takamino J; Takano K; Ieko M; Hashiguchi T; Nakagomi D (Joint bone spine, 2026)